PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Konggrid.194645.b, Hong Kong SAR, China.\', \'Department of Pathology and Immunology, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.\', \'Department of Internal Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.\', \'Fred Hutchinson Cancer Research Centergrid.270240.3, Seattle, Washington, USA.\', \'Department of Microbiology, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.\', \'Department of Pathology, LKS Faculty of Medicine, The University of Hong Konggrid.194645.b, Hong Kong, Hong Kong.\', \'Howard Hughes Medical Institute, Seattle, Washington, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1128/mBio.02395-21
?:hasPublicationType
?:journal
  • mBio
is ?:pmid of
?:pmid
?:pmid
  • 34517754
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.106
?:rankingScore_hIndex
  • 71
is ?:relation_isRelatedTo_publication of
?:title
  • Neutralizing Monoclonal Antibodies That Target the Spike Receptor Binding Domain Confer Fc Receptor-Independent Protection against SARS-CoV-2 Infection in Syrian Hamsters.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all